• Mashup Score: 2

    Autoimmune Pulmonary Alveolar Proteinosis (aPAP) is a rare lung disorder affecting approximately seven people per million. The disease affects individuals of all races, geographic regions, gender, and socioeconomic status. It has been diagnosed in individuals from 3 to 90 years of age. To share community perspectives on this rare disease, the National Organization for Rare Disorders (NORD) is proud to partner with the PAP Foundation to organize and host a virtual, externally led Patient-Focused Drug

    Tweet Tweets with this article
    • On Feb. 5, join the largest virtual gathering of the #Autoimmune Pulmonary Alveolar Proteinosis (#aPAP) community for a Patient-Focused Drug Development meeting hosted by NORD & @PAP_Foundation. Register now: https://t.co/QzGkDxCvBL #PulmonaryAlveolarProteinosis #PAP… https://t.co/kuDeLATk01 https://t.co/zXDC2w3RjZ

  • Mashup Score: 2

    Autoimmune Pulmonary Alveolar Proteinosis (aPAP) is a rare lung disorder affecting approximately seven people per million. The disease affects individuals of all races, geographic regions, gender, and socioeconomic status. It has been diagnosed in individuals from 3 to 90 years of age. To share community perspectives on this rare disease, the National Organization for Rare Disorders (NORD) is proud to partner with the PAP Foundation to organize and host a virtual, externally led Patient-Focused Drug

    Tweet Tweets with this article
    • On Feb. 5, join the largest virtual gathering of the #Autoimmune Pulmonary Alveolar Proteinosis (#aPAP) community for a Patient-Focused Drug Development meeting hosted by NORD & @PAP_Foundation. Register now: https://t.co/QzGkDxCvBL #PulmonaryAlveolarProteinosis #PAP… https://t.co/kuDeLATk01 https://t.co/zXDC2w3RjZ